These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 18976298)

  • 21. The utility of splenectomy as rescue treatment for severe acute antibody mediated rejection.
    Locke JE; Zachary AA; Haas M; Melancon JK; Warren DS; Simpkins CE; Segev DL; Montgomery RA
    Am J Transplant; 2007 Apr; 7(4):842-6. PubMed ID: 17391127
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antibody-mediated rejection in kidney transplantation: a review of pathophysiology, diagnosis, and treatment options.
    Kim M; Martin ST; Townsend KR; Gabardi S
    Pharmacotherapy; 2014 Jul; 34(7):733-44. PubMed ID: 24753207
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The use of eculizumab in renal transplantation.
    Barnett AN; Asgari E; Chowdhury P; Sacks SH; Dorling A; Mamode N
    Clin Transplant; 2013; 27(3):E216-29. PubMed ID: 23516966
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antibody-mediated kidney allograft rejection: therapeutic options and their experimental rationale.
    Fehr T; Gaspert A
    Transpl Int; 2012 Jun; 25(6):623-32. PubMed ID: 22394269
    [TBL] [Abstract][Full Text] [Related]  

  • 25. New treatments for acute humoral rejection of kidney allografts.
    Venetz JP; Pascual M
    Expert Opin Investig Drugs; 2007 May; 16(5):625-33. PubMed ID: 17461736
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Use of Eculizumab for Active Antibody-mediated Rejection That Occurs Early Post-kidney Transplantation: A Consecutive Series of 15 Cases.
    Tan EK; Bentall A; Dean PG; Shaheen MF; Stegall MD; Schinstock CA
    Transplantation; 2019 Nov; 103(11):2397-2404. PubMed ID: 30801549
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Eculizumab for Prevention of Antibody-Mediated Rejection in Blood Group-Incompatible Renal Transplantation.
    West-Thielke P; Progar K; Campara M; Jasiak N; Gallon L; Tang I; Spaggiari M; Tzvetanov I; Benedetti E
    Transplant Proc; 2018; 50(1):66-69. PubMed ID: 29407333
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Upfront use of eculizumab to treat early acute antibody-mediated rejection after kidney allotransplantation and relevance for xenotransplantation.
    Schwotzer N; Paganetti G; Barchi M; Perrottet N; Aubert V; Sadallah S; Rotman S; Venetz JP; Matter M; Golshayan D; Pascual M
    Xenotransplantation; 2020 Jul; 27(4):e12630. PubMed ID: 32698246
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The role of anticomplement therapy in the management of the kidney allograft.
    Kanbay M; Copur S; Yilmaz ZY; Baydar DE; Bilge I; Susal C; Kocak B; Ortiz A
    Clin Transplant; 2024 Mar; 38(3):e15277. PubMed ID: 38485664
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Late antibody-mediated rejection in renal allografts: outcome after conventional and novel therapies.
    Gupta G; Abu Jawdeh BG; Racusen LC; Bhasin B; Arend LJ; Trollinger B; Kraus E; Rabb H; Zachary AA; Montgomery RA; Alachkar N
    Transplantation; 2014 Jun; 97(12):1240-6. PubMed ID: 24937198
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Case Report: Splenic Irradiation for the Treatment of Chronic Active Antibody-Mediated Rejection in Kidney Allograft Recipients With
    Zhu L; Guo Z; Sa R; Guo H; Li J; Chen G
    Front Immunol; 2021; 12():661614. PubMed ID: 33936098
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Treatment of Antibody-Mediated Rejection in Kidney Transplantation: An Updated Systematic Review and Meta-Analysis.
    Wan SS; Ying TD; Wyburn K; Roberts DM; Wyld M; Chadban SJ
    Transplantation; 2018 Apr; 102(4):557-568. PubMed ID: 29315141
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Monitoring of complement activation biomarkers and eculizumab in complement-mediated renal disorders.
    Wehling C; Amon O; Bommer M; Hoppe B; Kentouche K; Schalk G; Weimer R; Wiesener M; Hohenstein B; Tönshoff B; Büscher R; Fehrenbach H; Gök ÖN; Kirschfink M
    Clin Exp Immunol; 2017 Feb; 187(2):304-315. PubMed ID: 27784126
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A refractory case of subclinical antibody-mediated rejection due to anti-HLA-DQ antibody in a kidney transplant patient.
    Fujimoto T; Nakada Y; Yamamoto I; Kobayashi A; Tanno Y; Yamada H; Miki J; Ohkido I; Tsuboi N; Yamamoto H; Yokoo T
    Nephrology (Carlton); 2015 Jul; 20 Suppl 2():81-5. PubMed ID: 26031594
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinicopathologic features and treatment response of early acute antibody-mediated rejection in Thai kidney transplant recipients: a single-center experience.
    Larpparisuth N; Vongwiwatana A; Vareesangthip K; Cheunsuchon B; Parichatikanon P; Premasathian N
    Transplant Proc; 2014; 46(2):474-6. PubMed ID: 24655992
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross-match-positive recipients.
    Montgomery RA; Zachary AA; Racusen LC; Leffell MS; King KE; Burdick J; Maley WR; Ratner LE
    Transplantation; 2000 Sep; 70(6):887-95. PubMed ID: 11014642
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of induction therapy protocols on transplant outcomes in crossmatch positive renal allograft recipients desensitized with IVIG.
    Vo AA; Toyoda M; Peng A; Bunnapradist S; Lukovsky M; Jordan SC
    Am J Transplant; 2006 Oct; 6(10):2384-90. PubMed ID: 16869794
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevention of acute vascular rejection by a functionally blocking anti-C5 monoclonal antibody combined with cyclosporine.
    Wang H; Jiang J; Liu W; Kubelik D; Chen G; Gies D; Garcia B; Zhong R; Rother RP
    Transplantation; 2005 May; 79(9):1121-7. PubMed ID: 15880054
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Complement inhibition as potential new therapy for antibody-mediated rejection.
    Eskandary F; Wahrmann M; Mühlbacher J; Böhmig GA
    Transpl Int; 2016 Apr; 29(4):392-402. PubMed ID: 26474721
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of acute antibody-mediated rejection: a single-center experience.
    Rodríguez Ferrero M; Rincón A; Bucalo L; Rementería A; Anaya F
    Transplant Proc; 2010 Oct; 42(8):2848-50. PubMed ID: 20970547
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.